Site icon OncologyTube

Daratumumab’s Main Limitation | Length of Infusion in Infusion-related Reactions

Ajai Chari, MD, Mt. Sinai, explains Daratumumab’s Main Limitation | Length of Infusion in Infusion-related Reactions at Annual Meeting 2018

Exit mobile version